Literature DB >> 12242724

Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro.

Holger Rumpold1, Elmar Heinrich, Gerold Untergasser, Martin Hermann, Gerald Pfister, Eugen Plas, Peter Berger.   

Abstract

BACKGROUND: Dispersed prostatic neuroendocrine cells are involved in growth regulation of the prostate and are considered to play a role in the pathogenesis of prostate carcinoma and benign prostatic hyperplasia (BPH). They are meant either to be derived from the neural crest during embryogenesis or by direct differentiation of the cells from locally present precursor cells.
METHODS: An in vitro model was developed for human prostatic epithelial and neuroendocrine cell differentiation. Minced explants from radical prostatectomies were seeded on collagen I-coated plates.
RESULTS: The majority of outgrowing cells were basal cells, positive for cytokeratin markers K 5/14 and CD 44, as determined by confocal laser scanning microscopy. A small fraction of interdispersed single cells expressing c-kit, which is found on pluripotent precursors, was identified by immunofluorescence. From these basal cells, in vitro differentiation of cells with neuroendocrine morphology could be achieved within 3 days. These were at rest, i.e., non-bromodeoxyuridine incorporating cells and characteristically coexpressed K 5/14, K 18, and the neuroendocrine marker chromogranin A. Luminal cells staining for K 8 or 18 were not observed.
CONCLUSION: Neuroendocrine differentiation of adult prostatic cells was achieved in vitro, favoring the hypothesis that neuroendocrine cells are derived from peripheral precursor cells. The acceleration of this differentiation pathway may be the reason for the increased presence of neuroendocrine cells in areas of epithelial hyperplasia in BPH. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242724     DOI: 10.1002/pros.10129

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

1.  Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.

Authors:  Ivan V Litvinov; Donald J Vander Griend; Yi Xu; Lizamma Antony; Susan L Dalrymple; John T Isaacs
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

2.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  Prostate epithelial stem cell culture.

Authors:  David L Hudson
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

4.  Carcinosarcoma of the prostate: two cases with distinctive morphologic and immunohistochemical findings.

Authors:  Noelia Perez; Mireia Castillo; Yolanda Santos; David Truan; Rafael Gutierrez; Agustin Franco; Antonio Palacin; Josep Antoni Bombi; Elias Campo; Pedro L Fernandez
Journal:  Virchows Arch       Date:  2005-04-09       Impact factor: 4.064

5.  Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics.

Authors:  Andrew S Goldstein; Devon A Lawson; Donghui Cheng; Wenyi Sun; Isla P Garraway; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

6.  Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.

Authors:  Wendy J Huss; Danny R Gray; Keyvan Tavakoli; Meghan E Marmillion; Lori E Durham; Mac A Johnson; Norman M Greenberg; Gary J Smith
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

7.  Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates.

Authors:  André Fujita; Luciana Rodrigues Gomes; João Ricardo Sato; Rui Yamaguchi; Carlos Eduardo Thomaz; Mari Cleide Sogayar; Satoru Miyano
Journal:  BMC Syst Biol       Date:  2008-12-05

8.  The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate.

Authors:  Jean Ching-Yi Tien; Lan Liao; Yonghong Liu; Zhaoliang Liu; Dong-Kee Lee; Fen Wang; Jianming Xu
Journal:  Int J Biol Sci       Date:  2014-10-02       Impact factor: 6.580

9.  Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.

Authors:  W Nathaniel Brennen; Yezi Zhu; Ilsa M Coleman; Susan L Dalrymple; Lizamma Antony; Radhika A Patel; Brian Hanratty; Roshan Chikarmane; Alan K Meeker; S Lilly Zheng; Jody E Hooper; Jun Luo; Angelo M De Marzo; Eva Corey; Jianfeng Xu; Srinivasan Yegnasubramanian; Michael C Haffner; Peter S Nelson; William G Nelson; William B Isaacs; John T Isaacs
Journal:  JCI Insight       Date:  2021-04-22

10.  Cytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells.

Authors:  Karine Vanoverberghe; V'yacheslav Lehen'kyi; Stéphanie Thébault; Maylis Raphaël; Fabien Vanden Abeele; Christian Slomianny; Pascal Mariot; Natalia Prevarskaya
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.